quinoxalines has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bua, A; Carta, A; Corona, P; Ibba, R; Molicotti, P; Piras, S | 1 |
1 other study(ies) available for quinoxalines and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
Quinoxaline-based efflux pump inhibitors restore drug susceptibility in drug-resistant nontuberculous mycobacteria.
Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Quinoxalines; Structure-Activity Relationship | 2022 |